Skip to main content

Find Clinical Trials

Home
Conditions
Cytokine Release Syndrome

Clinical trial condition

Cytokine Release Syndrome

Explore clinical trials studying Cytokine Release Syndrome. Study availability and eligibility vary by location and protocol.

89 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Cytokine Release Syndrome trial results

Completed

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

NCT04362813

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations: Novartis Investigative Site Birmingham, Alabama, United States

Novartis Investigative Site Glendale, California, United States

Novartis Investigative Site San Francisco, California, United States

Novartis Investigative Site San Francisco, California, United States

View all 39 locations

View Trial Details

Completed

A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

NCT04351243

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +19 more
Locations: Banner University Medical Center Phoenix, Arizona, United States

HonorHealth John C. Lincoln Medical Center Phoenix, Arizona, United States

HonorHealth Scottsdale Osborn Medical Center Scottsdale, Arizona, United States

HonorHealth Scottsdale, Arizona, United States

View all 33 locations

View Trial Details

Completed

Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS

NCT04374149

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations: Prisma Health Greenville, South Carolina, United States

View Trial Details

Completed

Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm

NCT04362137

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations: Novartis Investigative Site Fullerton, California, United States

Novartis Investigative Site Aurora, Colorado, United States

Novartis Investigative Site Denver, Colorado, United States

Novartis Investigative Site Atlanta, Georgia, United States

View all 61 locations

View Trial Details

Completed

Menstrual Blood Stem Cells in Severe Covid-19

NCT05019287

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +17 more
Locations: Avicenna Research Institute Tehran, Iran

View Trial Details

Completed

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

NCT02761915

Conditions: Cytokine Release Syndrome, Disease Attributes, Inflammation, +16 more
Locations: University College London Institute of Child Health & Great Ormond Street Hospital London, United Kingdom

View Trial Details

Completed

Efficacy and Safety of Itolizumab in COVID-19 Complications

NCT04475588

Conditions: Acute Respiratory Distress Syndrome, COVID-19, Coronaviridae Infections, +19 more
Locations: Topiwala National Medical College & B. Y. L. Nair Charitable Hospital, Mumbai, India

Seth GS Medical College and KEM Hospital Mumbai, India

MAMC medical college and Lok Nayak Jai Prakash Narayan Hospital hospital New Delhi, India

All India Institute Of Medical Sciences New Delhi, India

View Trial Details

Completed

Cytokine Adsorption in Severe, Refractory Septic Shock

NCT04910893

Conditions: Cytokine Release Syndrome, Cytokine Storm, Infections, +8 more
Locations: Not specified

View Trial Details

Completed

Cytokine Hemoadsorption in ECMO Patients

NCT04901338

Conditions: ARDS, Human, Cardiac Arrest, Cardiogenic Shock, +26 more
Locations: University Medical Center Ljubljana Ljubljana, Slovenia

View Trial Details

Completed

Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia

NCT04873141

Conditions: COVID-19 Pneumonia, Cytokine Release Syndrome, Inflammation, +4 more
Locations: Shaheed Zulfiqar Ali Bhutto Medical University Islamabad, Pakistan

View Trial Details